Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 266,904,544
  • Shares Outstanding, K 2,112,422
  • Annual Sales, $ 51,722 M
  • Annual Income, $ 11,941 M
  • EBIT $ 17,558 M
  • EBITDA $ 23,672 M
  • 60-Month Beta 0.60
  • Price/Sales 5.31
  • Price/Cash Flow 11.83
  • Price/Book 5.97

Options Overview Details

View History
  • Implied Volatility 18.60% ( +1.05%)
  • Historical Volatility 20.67%
  • IV Percentile 12%
  • IV Rank 7.71%
  • IV High 43.36% on 04/08/25
  • IV Low 16.54% on 12/13/24
  • Put/Call Vol Ratio 1.82
  • Today's Volume 4,038
  • Volume Avg (30-Day) 2,487
  • Put/Call OI Ratio 1.43
  • Today's Open Interest 66,113
  • Open Int (30-Day) 58,578

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.00
  • Number of Estimates 2
  • High Estimate 2.09
  • Low Estimate 1.90
  • Prior Year 1.98
  • Growth Rate Est. (year over year) +1.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.57 +3.93%
on 10/29/25
133.16 -5.11%
on 10/08/25
-5.20 (-3.95%)
since 10/07/25
3-Month
115.75 +9.16%
on 08/08/25
133.55 -5.39%
on 10/06/25
+10.43 (+9.00%)
since 08/07/25
52-Week
96.06 +31.53%
on 12/20/24
133.55 -5.39%
on 10/06/25
+19.27 (+18.00%)
since 11/07/24

Most Recent Stories

More News
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) on Monday rose by +1.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose by +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose by +1.82%. December E-mini S&P...

MSTR : 241.93 (+1.99%)
CADE : 38.43 (+2.29%)
AAPL : 268.47 (-0.48%)
RNA : 69.84 (+0.09%)
HBAN : 15.69 (+1.75%)
NVS : 126.35 (-0.17%)
$IUXX : 25,059.81 (-0.28%)
COIN : 309.14 (+4.72%)
ZNZ25 : 112-185 (-0.25%)
TSLA : 429.52 (-3.68%)
ESZ25 : 6,813.25 (+0.88%)
QCOM : 170.89 (-1.33%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. December E-mini S&P futures (ESZ25 )...

CADE : 38.43 (+2.29%)
RNA : 69.84 (+0.09%)
HBAN : 15.69 (+1.75%)
NVS : 126.35 (-0.17%)
$IUXX : 25,059.81 (-0.28%)
COIN : 309.14 (+4.72%)
ZNZ25 : 112-185 (-0.25%)
TSLA : 429.52 (-3.68%)
ESZ25 : 6,813.25 (+0.88%)
QCOM : 170.89 (-1.33%)
AWK : 130.84 (+1.03%)
KDP : 25.96 (-1.52%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.32%. December E-mini S&P futures (ESZ25 )...

MSTR : 241.93 (+1.99%)
CADE : 38.43 (+2.29%)
RNA : 69.84 (+0.09%)
HBAN : 15.69 (+1.75%)
NVS : 126.35 (-0.17%)
$IUXX : 25,059.81 (-0.28%)
COIN : 309.14 (+4.72%)
ZNZ25 : 112-185 (-0.25%)
TSLA : 429.52 (-3.68%)
ESZ25 : 6,813.25 (+0.88%)
KDP : 25.96 (-1.52%)
^ETCUSD : 17.24319 (-3.69%)
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END

BCAX : 14.64 (+0.48%)
OTLC : 0.0979 (-0.61%)
IOBT : 0.9017 (+6.96%)
NVS : 126.35 (-0.17%)
PFE : 24.43 (-1.69%)
BoC Announcement Due Next Week

Monday U.S. Economic Lookahead Durable-goods orders (Sept.) Featured Earnings ...

GOOG : 279.70 (-1.98%)
META : 621.71 (+0.45%)
AAPL : 268.47 (-0.48%)
CVX : 155.02 (+1.36%)
WELL : 190.25 (+1.33%)
NVS : 126.35 (-0.17%)
ABBV : 219.16 (+0.05%)
UNH : 324.21 (+0.82%)
MSFT : 496.82 (-0.06%)
WM : 201.92 (+1.15%)
V : 336.02 (-0.28%)
XOM : 117.22 (+2.38%)
BoC Announcement Due Next Week

Monday U.S. Economic Lookahead Durable-goods orders (Sept.) Featured Earnings ...

GOOG : 279.70 (-1.98%)
META : 621.71 (+0.45%)
AAPL : 268.47 (-0.48%)
CVX : 155.02 (+1.36%)
WELL : 190.25 (+1.33%)
NVS : 126.35 (-0.17%)
ABBV : 219.16 (+0.05%)
UNH : 324.21 (+0.82%)
MSFT : 496.82 (-0.06%)
WM : 201.92 (+1.15%)
V : 336.02 (-0.28%)
XOM : 117.22 (+2.38%)
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novartis AG, with a price target of CHF95.00. The company’s shares opened today at CHF106.36.Elevate Your Investing Strategy:...

NVS : 126.35 (-0.17%)
Should You Buy Novartis Stock Before October 28?

Novartis is gaining traction this year, but can the trend continue?

GLUE : 12.31 (-5.38%)
SDZNY : 65.9400 (-1.93%)
NVS : 126.35 (-0.17%)
Barclays Reaffirms Their Sell Rating on Novartis AG (NOVN)

In a report released today, Shirley Chen from Barclays maintained a Sell rating on Novartis AG, with a price target of CHF90.00. The company’s shares closed yesterday at CHF105.80.Elevate Your Investing...

NVS : 126.35 (-0.17%)
Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG today and set a price target of CHF120.00. The company’s shares opened today at CHF105.22.Elevate Your Investing Strategy:...

NVS : 126.35 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 127.83
2nd Resistance Point 127.40
1st Resistance Point 126.87
Last Price 126.35
1st Support Level 125.91
2nd Support Level 125.48
3rd Support Level 124.95

See More

52-Week High 133.55
Last Price 126.35
Fibonacci 61.8% 119.23
Fibonacci 50% 114.81
Fibonacci 38.2% 110.38
52-Week Low 96.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar